UB Paderborn / Katalog / Suche / in CDI

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.2009-2021

2021

Volltextzugriff (PDF)

Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients

Scientific reports, 2022-06, Vol.12 (1), p.10617-10617, Article 10617

2022

Volltextzugriff (PDF)

Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold

International journal of clinical oncology, 2020-03, Vol.25 (3), p.472-478

2020

Volltextzugriff (PDF)

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

BMC cancer, 2017-05, Vol.17 (1), p.372-372, Article 372

2017

Volltextzugriff (PDF)

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

Cancer Immunology, Immunotherapy, 2020-05, Vol.69 (5), p.689-702

2020

Volltextzugriff (PDF)

Transperitoneal laparoscopic umbilical resection of urachal remnants: a feasible surgical method

BMC urology, 2023-04, Vol.23 (1), p.57-57, Article 57

2023

Volltextzugriff (PDF)

Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy

International journal of clinical oncology, 2017-02, Vol.22 (1), p.174-180

2017

Volltextzugriff (PDF)

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer

BMC cancer, 2018-05, Vol.18 (1), p.493-493, Article 493

2018

Volltextzugriff (PDF)

Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications

International Brazilian journal of urology, 2019-01, Vol.45 (1), p.169-178

2019

Volltextzugriff (PDF)

Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With α-Blockers

International neurourology journal, 2017-09, Vol.21 (3), p.197-203

2017

Volltextzugriff (PDF)

Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With α1-Blockers

International Neurourology Journal, 2017, 21(3), , pp.197-203

2017

Volltextzugriff (PDF)

Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib

Japanese journal of clinical oncology, 2013-10, Vol.43 (10), p.1023-1029

2013

Volltextzugriff (PDF)

Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy

International journal of clinical oncology, 2018-04, Vol.23 (2), p.338-346

2018

Volltextzugriff (PDF)

Acute Kidney Injury Associated with Renal Cell Carcinoma Complicated by Renal Vein and Inferior Vena Cava Involvement

Internal Medicine, 2016/09/01, Vol.55(17), pp.2447-2452

2016

Volltextzugriff (PDF)

Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy

BMC urology, 2017-06, Vol.17 (1), p.47-47, Article 47

2017

Volltextzugriff (PDF)

Flank Pain, Nausea, Vomiting and Hypotension in a Chronic Hemodialysis Patient with a Spontaneous Perirenal Hemorrhage

Internal Medicine, 2013, Vol.52(18), pp.2083-2086

2013

Volltextzugriff (PDF)

Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience

International journal of clinical oncology, 2011-12, Vol.16 (6), p.630-636

2011

Volltextzugriff (PDF)

Persistence and adherence of solifenacin treatment for Japanese women with overactive bladder

Urogynaecologia international journal, 2012-10, Vol.26 (1), p.9

2012

Volltextzugriff (PDF)

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience

BMC urology, 2012-02, Vol.12 (1), p.3-3, Article 3

2012

Volltextzugriff (PDF)

Clinical Significance of 18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma

Anticancer research, 2021-10, Vol.41 (10), p.5179

2021

Volltextzugriff (PDF)

Clinical Significance of 18 F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma

Anticancer research, 2021-10, Vol.41 (10), p.5179-5188

2021

Volltextzugriff (PDF)

Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3‐Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?

Lower urinary tract symptoms, 2018-05, Vol.10 (2), p.158-166

2018

Volltextzugriff (PDF)

Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-α, and tegafur-uracil: a single-institution experience

International journal of clinical oncology, 2008-06, Vol.13 (3), p.257-262, Article 257

2008

Volltextzugriff (PDF)

Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma

BMJ case reports, 2020-09, Vol.13 (9), p.e235199

2020

Volltextzugriff (PDF)

Successful management of ureteral injury after gender-affirming laparoscopic hysterectomy: A case report

International journal of surgery case reports, 2022-10, Vol.99, p.107684, Article 107684

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival

Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients

Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

Transperitoneal laparoscopic umbilical resection of urachal remnants: a feasible surgical method

Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy

Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer

Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications

Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With α-Blockers

Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With α1-Blockers

Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib

Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy

Acute Kidney Injury Associated with Renal Cell Carcinoma Complicated by Renal Vein and Inferior Vena Cava Involvement

Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy

Flank Pain, Nausea, Vomiting and Hypotension in a Chronic Hemodialysis Patient with a Spontaneous Perirenal Hemorrhage

Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience

Persistence and adherence of solifenacin treatment for Japanese women with overactive bladder

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience

Clinical Significance of 18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma

Clinical Significance of 18 F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma

Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3‐Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?

Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-α, and tegafur-uracil: a single-institution experience

Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma

Successful management of ureteral injury after gender-affirming laparoscopic hysterectomy: A case report

Suchergebnisse filtern